These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38944978)

  • 1. Generation of two iPSC lines from vascular Ehlers-Danlos Syndrome (vEDS) patients carrying a missense mutation in COL3A1 gene.
    Manhas A; Tripathi D; Noishiki C; Wu D; Liu L; Sallam K; Lee JT; Fukaya E; Sayed N
    Stem Cell Res; 2024 Sep; 79():103485. PubMed ID: 38944978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers-Danlos Syndrome with Mutations in
    Utama S; Cale JM; Mitrpant C; Fletcher S; Wilton SD; Aung-Htut MT
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of the human induced pluripotent stem cell line (IBKMOLi003-A) from PBMCs of a vascular Ehlers-Danlos syndrome (vEDS) patient carrying the heterozygous nonsense mutation c.430C > T (p.Q105*) in the COL3A1 gene.
    Höpperger S; Spathopoulou A; Mayer-Suess L; Suarez-Cubero M; Sillaber K; Spreiz A; Kiechl S; Edenhofer F; Fellner L
    Stem Cell Res; 2024 Mar; 75():103321. PubMed ID: 38301384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.
    Shalhub S; Byers PH; Hicks KL; Charlton-Ouw K; Zarkowsky D; Coleman DM; Davis FM; Regalado ES; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Behrendt CA; Debus ES; von Kodolitsch Y; Powell RJ; Pepin M; Milewicz DM; Lawrence PF; Woo K
    J Vasc Surg; 2019 Nov; 70(5):1543-1554. PubMed ID: 31126764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived extracellular matrix demonstrates role of COL3A1 in blood vessel mechanics.
    Doherty EL; Aw WY; Warren EC; Hockenberry M; Whitworth CP; Krohn G; Howell S; Diekman BO; Legant WR; Nia HT; Hickey AJ; Polacheck WJ
    Acta Biomater; 2023 Aug; 166():346-359. PubMed ID: 37187299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular Ehlers-Danlos Syndrome With a Novel Missense COL3A1 Mutation Present With Pulmonary Complications and Iliac Arterial Dissection.
    Gu G; Yang H; Cui L; Fu Y; Li F; Zhou Z; Zheng Y
    Vasc Endovascular Surg; 2018 Feb; 52(2):138-142. PubMed ID: 29216800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.
    Chiarelli N; Carini G; Zoppi N; Ritelli M; Colombi M
    PLoS One; 2018; 13(1):e0191220. PubMed ID: 29346445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic artery pathology presentation, operative interventions, and outcomes in 88 patients with vascular Ehlers-Danlos syndrome.
    Shalhub S; Nkansah R; El-Ghazali A; Hillenbrand CJ; Vaidya SS; Schwarze U; Byers PH
    J Vasc Surg; 2023 Aug; 78(2):394-404. PubMed ID: 37068529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic aspects of the vascular type of Ehlers-Danlos syndrome (vEDS, EDSIV) in Japan.
    Watanabe A; Kosho T; Wada T; Sakai N; Fujimoto M; Fukushima Y; Shimada T
    Circ J; 2007 Feb; 71(2):261-5. PubMed ID: 17251678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent pneumothorax and intrapulmonary cavitary lesions in a male patient with vascular Ehlers-Danlos syndrome and a novel missense mutation in the COL3A1 gene: a case report.
    Wan T; Ye J; Wu P; Cheng M; Jiang B; Wang H; Li J; Ma J; Wang L; Huang X
    BMC Pulm Med; 2020 May; 20(1):149. PubMed ID: 32471395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
    D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
    Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Ehlers-Danlos syndrome with a Novel missense COL3A1 gene mutation present with bilateral spontaneous carotid-cavernous fistula: a case report.
    Tatebayashi K; Shirakawa M; Abe S; Fujita M; Yoshimura S
    Acta Neurochir (Wien); 2023 Dec; 165(12):3799-3804. PubMed ID: 37917379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical COL3A1 variants (glutamic acid to lysine) cause vascular Ehlers-Danlos syndrome with a consistent phenotype of tissue fragility and skin hyperextensibility.
    Ghali N; Baker D; Brady AF; Burrows N; Cervi E; Cilliers D; Frank M; Germain DP; Hulmes DJS; Jacquemont ML; Kannu P; Lefroy H; Legrand A; Pope FM; Robertson L; Vandersteen A; von Klemperer K; Warburton R; Whiteford M; van Dijk FS
    Genet Med; 2019 Sep; 21(9):2081-2091. PubMed ID: 30837697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular Ehlers-Danlos Syndrome: A Comprehensive Natural History Study in a Dutch National Cohort of 142 Patients.
    Demirdas S; van den Bersselaar LM; Lechner R; Bos J; Alsters SIM; Baars MJH; Baas AF; Baysal Ö; van der Crabben SN; Dulfer E; Giesbertz NAA; Helderman-van den Enden ATJM; Hilhorst-Hofstee Y; Kempers MJE; Komdeur FL; Loeys B; Majoor-Krakauer D; Ockeloen CW; Overwater E; van Tintelen PJ; Voorendt M; de Waard V; Maugeri A; Brüggenwirth HT; van de Laar IMBH; Houweling AC
    Circ Genom Precis Med; 2024 Jun; 17(3):e003978. PubMed ID: 38623759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two closely spaced missense COL3A1 variants in cis cause vascular Ehlers-Danlos syndrome in one large Chinese family.
    Liang M; Chen C; Dai Y; Chang Y; Gao Y
    J Cell Mol Med; 2022 Jan; 26(1):144-150. PubMed ID: 34845833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical artery dissections and type A aortic dissection in a family with a novel missense COL3A1 mutation of vascular type Ehlers-Danlos syndrome.
    Makrygiannis G; Loeys B; Defraigne JO; Sakalihasan N
    Eur J Med Genet; 2015 Nov; 58(11):634-6. PubMed ID: 26497932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in COL3A1 associates to vascular Ehlers-Danlos syndrome with predominant musculoskeletal involvement.
    Ruscitti F; Trevisan L; Rosti G; Gotta F; Cianflone A; Geroldi A; Origone P; Pichiecchio A; Viglio S; Iascone M; Mandich P
    Mol Genet Genomic Med; 2021 Sep; 9(9):e1753. PubMed ID: 34318601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis.
    Shalhub S; Byers PH; Hicks KL; Coleman DM; Davis FM; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Charlton-Ouw K; Behrendt CA; Debus ES; von Kodolitsch Y; Zarkowsky D; Powell RJ; Pepin M; Milewicz DM; Regalado ES; Lawrence PF; Woo K
    J Vasc Surg; 2020 Jan; 71(1):149-157. PubMed ID: 31353273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous pneumothorax and hemothorax frequently precede the arterial and intestinal complications of vascular Ehlers-Danlos syndrome.
    Shalhub S; Neptune E; Sanchez DE; Dua A; Arellano N; McDonnell NB; Milewicz DM
    Am J Med Genet A; 2019 May; 179(5):797-802. PubMed ID: 30793832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive genetic screening for vascular Ehlers-Danlos syndrome through an amplification-based next-generation sequencing system.
    Yamaguchi T; Hayashi S; Hayashi D; Matsuyama T; Koitabashi N; Ogiwara K; Noda M; Nakada C; Fujiki S; Furutachi A; Tanabe Y; Yamanaka M; Ishikawa A; Mizukami M; Mizuguchi A; Sugiura K; Sumi M; Yamazawa H; Izawa A; Wada Y; Fujikawa T; Takiguchi Y; Wakui K; Takano K; Nishio SY; Kosho T
    Am J Med Genet A; 2023 Jan; 191(1):37-51. PubMed ID: 36189931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.